| Alison Morris Schryver, PT, DPT | |
|
401 Seacoast Pkwy Unit D, Mount Pleasant, SC 29464-8263 | |
| (843) 969-2201 | |
| (843) 969-2202 |
| Full Name | Alison Morris Schryver |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 14 Years |
| Location | 401 Seacoast Pkwy Unit D, Mount Pleasant, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003199209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 6238 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Private Therapy Services Llc | 7810978616 | 14 |
News Archive
Nanotherapeutics announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.
A small study of Toronto college students is shedding light on a contributing factor of insomnia that might be hard to admit - an adult fear of the dark.
Kamyar Kalantar-Zadeh, M.D., M.P.H., Ph.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), is the author of an invited editorial in JAMA. The editorial accompanied a study that included data from more than 1 million adults, and indicated the use of a newer risk prediction equation that classified fewer individuals as having chronic kidney disease and more accurately categorized the risk for death and end-stage renal disease.
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
A new study released by Houston Methodist takes researchers a significant step closer to developing a uniform, universal COVID-19 antibody test.
› Verified 3 days ago
| Provider Name | Private Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1346381092 PECOS PAC ID: 7810978616 Enrollment ID: O20040527000462 |
News Archive
Nanotherapeutics announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.
A small study of Toronto college students is shedding light on a contributing factor of insomnia that might be hard to admit - an adult fear of the dark.
Kamyar Kalantar-Zadeh, M.D., M.P.H., Ph.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), is the author of an invited editorial in JAMA. The editorial accompanied a study that included data from more than 1 million adults, and indicated the use of a newer risk prediction equation that classified fewer individuals as having chronic kidney disease and more accurately categorized the risk for death and end-stage renal disease.
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
A new study released by Houston Methodist takes researchers a significant step closer to developing a uniform, universal COVID-19 antibody test.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alison Morris Schryver, PT, DPT 401 Seacoast Pkwy Unit D, Mount Pleasant, SC 29464-8263 Ph: (843) 969-2201 | Alison Morris Schryver, PT, DPT 401 Seacoast Pkwy Unit D, Mount Pleasant, SC 29464-8263 Ph: (843) 969-2201 |
News Archive
Nanotherapeutics announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.
A small study of Toronto college students is shedding light on a contributing factor of insomnia that might be hard to admit - an adult fear of the dark.
Kamyar Kalantar-Zadeh, M.D., M.P.H., Ph.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), is the author of an invited editorial in JAMA. The editorial accompanied a study that included data from more than 1 million adults, and indicated the use of a newer risk prediction equation that classified fewer individuals as having chronic kidney disease and more accurately categorized the risk for death and end-stage renal disease.
About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.
A new study released by Houston Methodist takes researchers a significant step closer to developing a uniform, universal COVID-19 antibody test.
› Verified 3 days ago
Mrs. Mariesa Eikevik, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3559 Franklin Tower Dr, Mount Pleasant, SC 29466 Phone: 571-244-7206 Fax: 854-227-5165 | |
Go Pt Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2911 Old Tavern Ct, Mount Pleasant, SC 29466 Phone: 843-609-0123 | |
Kelli Whitsitt, MSR, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1535 Barquentine Dr, Mount Pleasant, SC 29464 Phone: 843-270-1594 | |
Deanna Smoak, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 320 W Coleman Blvd Ste B, Mount Pleasant, SC 29464 Phone: 843-823-5133 Fax: 843-806-4997 | |
Ms. Heather Nicole Chumley-jones, MSRPT, RYT200 Physical Therapist Medicare: Medicare Enrolled Practice Location: 3409 Salterbeck Ct, Suite 202, Mount Pleasant, SC 29466 Phone: 843-972-0671 | |
Coastal Carolina Physical Therapy Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3014 S Morgans Pt Rd Ste D, Mount Pleasant, SC 29466 Phone: 843-284-8092 |